• Educational Program: Educational Sessions and Methods Workshops 
• Plenary Sessions 
• Presidential Select Symposium  
• Major Symposia 
• Advances in Diagnostics and Therapeutics 
• Advances in Early Detection and Interception  
• Advances in Hematologic Malignancies 
• Advances in Organ Site Research 
• Advances in Population Sciences 
• Advances in Prevention Research 
• Advances in the Science of Cancer Disparities 
• Advances in Technologies 
• Forums and Special Sessions 
• New Drugs on the Horizon Sessions 
• Science and Public Policy Program 

Beginning at 3:00 p.m. on Friday, April 25, and continuing all day Saturday, April 26, 2025, a program of Educational Sessions and Methods Workshops will be presented. The program on Saturday will conclude with the Discovery Science Plenary Session titled, “Novel Mechanisms Influencing Cancer Evolution,” (4:15 p.m.-6:15 p.m.) The Opening Ceremony and the Opening Plenary Session will take place on Sunday morning, April 27. The meeting will conclude at 1:30 p.m. on Wednesday, April 30.  The 2025 Program in Progress follows: 

Educational Program: Educational Sessions and Methods Workshops 

The Educational Program is an integral part of the meeting and provides attendees with an opportunity to expand their knowledge base in new and exciting fields. Add the Educational Program Pass to your registration to access this important program. The Educational Program consists of more than 65 unique sessions covering all areas of cancer research and features updates on critical topics and new technologies. As part of these sessions, the following popular sessions and topics will be included. More information will be posted as it becomes available. 

• Tumor Immunology and Immunotherapy for Nonimmunologists. This exciting session is part of the yearly programming presented at the AACR Annual Meeting and organized in conjunction with the AACR Cancer Immunology Working Group. This popular session provides a comprehensive review of hot topics in the field and allows ample time for questions from the audience. 

• Chemistry to the Clinic. This multi-part series, organized in conjunction with the AACR Chemistry in Cancer Research Working Group, provides meeting attendees with foundational knowledge of critical elements of the cancer drug design and development process, such as lead optimization and identification of molecular targets and novel drug modalities. 

• Clinical Trial Design. These Methods Workshops will provide attendees with a historical and methodologic understanding of clinical trials and demonstrate how to design an appropriate trial to answer the scientific questions presented by emerging treatments. Sessions will also focus on biostatistics in clinical trials. 

• Data Science. Several sessions will focus on exciting advances and emerging opportunities in cancer research. Sessions will also explore the integration of data science in advancing cancer science and medicine.